Home → Anxiety Treatment NYC

Anxiety Disorder Treatment in NYC: A Comprehensive Psychiatrist's Guide

By Ryan S. Sultan, MD
Assistant Professor of Clinical Psychiatry, Columbia University Irving Medical Center
Board-Certified in Adult Psychiatry and Child & Adolescent Psychiatry
March 29, 2026

Understanding Anxiety Disorders: More Than Just Worry

Everyone experiences anxiety. It is a normal, adaptive response that kept our ancestors alive by preparing the body to face threats. The problem arises when anxiety becomes chronic, disproportionate to the situation, and begins to impair your ability to function at work, in relationships, and in daily life.

As a psychiatrist at Columbia University who treats anxiety disorders daily, I see patients across the full spectrum -- from executives who cannot sleep before presentations to teenagers paralyzed by social situations, to parents who cannot stop catastrophizing about their children's safety. What they all share is a brain that has become stuck in a threat-detection mode it cannot turn off.

Anxiety disorders are not a character flaw, weakness, or something you can simply "think your way out of." They are medical conditions with identifiable neurobiological underpinnings that respond to targeted treatment. The National Institute of Mental Health estimates that 31.1% of U.S. adults experience an anxiety disorder at some point in their lives, making them the single most prevalent category of psychiatric illness.

The Neurobiology of Anxiety

Understanding what happens in the anxious brain helps explain why anxiety feels so overwhelming and why specific treatments work.

The amygdala is the brain's alarm system. In anxiety disorders, it becomes hyperactive -- responding to non-threatening stimuli as if they were dangerous. Neuroimaging studies consistently show exaggerated amygdala activation in patients with anxiety disorders compared to healthy controls.

The prefrontal cortex (PFC) normally acts as a brake on the amygdala, providing top-down regulation that says, "This is not actually dangerous." In anxiety disorders, this regulatory function is impaired. The PFC cannot effectively inhibit amygdala responses, leading to runaway fear and worry.

Key neurotransmitter systems involved:

• Serotonin: Modulates mood, worry, and obsessive thinking. Low serotonergic tone is associated with anxiety. This is why SSRIs are first-line treatment.
• GABA (gamma-aminobutyric acid): The brain's primary inhibitory neurotransmitter. Reduced GABA activity leads to neural hyperexcitability and anxiety. Benzodiazepines enhance GABA transmission.
• Norepinephrine: Drives the fight-or-flight response. Excessive noradrenergic activity produces the physical symptoms of anxiety -- racing heart, sweating, trembling.
• Glutamate: The brain's primary excitatory neurotransmitter. Excessive glutamate signaling contributes to the neural hyperexcitability seen in anxiety.

The hypothalamic-pituitary-adrenal (HPA) axis also plays a critical role. Chronic anxiety leads to sustained cortisol elevation, which in turn impairs hippocampal function (affecting memory and context-dependent learning) and further sensitizes the amygdala. This creates a vicious cycle where anxiety literally rewires the brain to become more anxious.

Types of Anxiety Disorders

Generalized Anxiety Disorder (GAD)

GAD is characterized by persistent, excessive worry about multiple domains of life -- work, health, finances, family, minor matters -- that the person finds difficult to control. It is not worry about one specific thing; it is a pervasive state of apprehension that shifts from topic to topic.

Diagnostic criteria require:

• Excessive anxiety and worry occurring more days than not for at least 6 months
• Difficulty controlling the worry
• Three or more of: restlessness, fatigue, difficulty concentrating, irritability, muscle tension, sleep disturbance
• Clinically significant distress or impairment

GAD affects approximately 6.8 million American adults (3.1% of the population) and is twice as common in women as men. It typically develops gradually, with many patients unable to recall a time they were not anxious. The average age of onset is 31, but many patients report lifelong anxiety dating back to childhood.

What makes GAD particularly insidious is that the worry feels productive to the patient. They often believe that worrying prevents bad outcomes or prepares them for the worst. In reality, the worry is consuming cognitive resources, impairing sleep, creating muscle tension and physical symptoms, and providing zero actual protection against negative events.

Social Anxiety Disorder (Social Phobia)

Social anxiety disorder involves marked fear or anxiety about one or more social situations in which the person is exposed to possible scrutiny by others. The core fear is being judged, embarrassed, humiliated, or rejected.

Common triggers include:

• Public speaking or presentations
• Meeting new people or making small talk
• Eating or drinking in front of others
• Being the center of attention
• Using public restrooms
• Making phone calls
• Attending parties or social gatherings

Social anxiety disorder affects approximately 15 million American adults (7.1% of the population). It typically begins in the early to mid-teens, and without treatment, it tends to be chronic and can lead to significant occupational and interpersonal impairment. Many patients with social anxiety avoid career advancement, romantic relationships, and social connections -- not because they do not want these things, but because the anxiety makes them feel impossible.

I see this commonly in my New York City practice. High-achieving professionals who are excellent at their jobs but terrified of networking events, team meetings, or asking for a promotion. The irony is that social anxiety often affects intelligent, thoughtful, empathic people who would do well in social situations if the anxiety were not getting in the way.

Panic Disorder

Panic disorder is characterized by recurrent, unexpected panic attacks -- sudden surges of intense fear or discomfort that peak within minutes and involve four or more physical or cognitive symptoms.

Symptoms of a panic attack:

• Pounding or racing heart (palpitations)
• Sweating
• Trembling or shaking
• Shortness of breath or sensation of smothering
• Chest pain or discomfort
• Nausea or abdominal distress
• Dizziness, lightheadedness, or faintness
• Chills or hot flushes
• Numbness or tingling (paresthesias)
• Derealization or depersonalization
• Fear of losing control or "going crazy"
• Fear of dying

The hallmark of panic disorder -- as opposed to isolated panic attacks -- is persistent concern about having additional attacks and/or maladaptive behavioral changes because of the attacks (such as avoiding exercise, leaving home, or going to certain places). Many patients develop agoraphobia, avoiding situations where they fear a panic attack might occur or escape might be difficult.

Panic disorder affects approximately 6 million American adults (2.7% of the population). It often begins in the late teens or early 20s and is twice as common in women. Many patients first present to emergency rooms convinced they are having a heart attack, only to be told their heart is fine and they are "just anxious." This dismissal can be profoundly frustrating and often delays proper treatment.

Specific Phobias

Specific phobias involve marked fear or anxiety about a specific object or situation -- such as flying, heights, animals, blood, injections, or enclosed spaces. The fear is out of proportion to the actual danger, the person recognizes this, and yet they cannot control it.

Specific phobias are the most common anxiety disorder, affecting approximately 19 million American adults (8.7% of the population). They typically develop in childhood and, without treatment, tend to persist into adulthood. While some phobias cause minimal impairment (a fear of snakes rarely affects daily life in Manhattan), others can be highly disabling -- fear of flying can limit career opportunities, fear of blood/injections can prevent people from seeking medical care.

Separation Anxiety Disorder

While typically associated with children, separation anxiety disorder can occur in adults. It involves excessive fear or anxiety about separation from attachment figures, to a degree that is developmentally inappropriate and causes significant distress or impairment.

Adult separation anxiety is more common than previously recognized, with some estimates suggesting a lifetime prevalence of 6.6%. It often manifests as excessive worry about harm befalling loved ones, reluctance to leave home or be alone, nightmares about separation, and physical symptoms when separation occurs or is anticipated.

How Anxiety Differs from ADHD: Overlapping Symptoms, Different Causes

One of my areas of particular expertise is distinguishing anxiety from ADHD -- and treating both when they co-occur. This distinction matters enormously because treatment is different for each condition, and misdiagnosis leads to ineffective treatment or even worsening symptoms.

Symptoms that overlap between anxiety and ADHD:

Approximately 25-50% of adults with ADHD also have a co-occurring anxiety disorder. When both conditions are present, treatment requires careful sequencing. In my practice, I typically determine which condition is primary -- meaning which one is driving the most impairment -- and address that first. In some cases, treating ADHD with stimulant medication actually reduces anxiety because the patient gains executive function control and stops feeling overwhelmed. In other cases, stimulants worsen anxiety and we need to stabilize the anxiety first.

The key diagnostic question I ask is: "When did this start?" ADHD is neurodevelopmental -- it has been present since childhood. Anxiety can develop at any age. A patient who was a focused, calm child but developed concentration difficulties at age 30 likely has anxiety, not ADHD. A patient who has struggled with attention, organization, and impulsivity since elementary school likely has ADHD, possibly with secondary anxiety from years of underperformance and criticism.

For more on this topic, see my detailed guide on ADHD vs. Anxiety: How to Tell the Difference.

Treatment Options for Anxiety Disorders

First-Line Medications: SSRIs and SNRIs

Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are the cornerstone of pharmacological anxiety treatment. They are effective, non-addictive, and generally well-tolerated.

SSRIs commonly used for anxiety:

• Sertraline (Zoloft): FDA-approved for panic disorder, social anxiety disorder, PTSD, and OCD. Often my first choice due to broad efficacy and favorable side effect profile.
• Escitalopram (Lexapro): FDA-approved for GAD. Well-tolerated with few drug interactions.
• Paroxetine (Paxil): FDA-approved for GAD, social anxiety disorder, panic disorder, and OCD. Effective but can cause more weight gain and has a more difficult discontinuation syndrome.
• Fluoxetine (Prozac): FDA-approved for panic disorder and OCD. Long half-life makes missed doses less problematic.

SNRIs commonly used for anxiety:

• Venlafaxine XR (Effexor XR): FDA-approved for GAD, social anxiety disorder, and panic disorder. Particularly effective for anxiety with comorbid depression. Can increase blood pressure at higher doses.
• Duloxetine (Cymbalta): FDA-approved for GAD. Also helps with pain syndromes, which commonly co-occur with chronic anxiety.

What to expect when starting an SSRI or SNRI for anxiety: These medications take 4-6 weeks to reach full therapeutic effect. During the first 1-2 weeks, anxiety may temporarily increase before improving -- this is a common and expected phenomenon that I prepare all patients for. Starting at a low dose and titrating up gradually minimizes this initial activation. Side effects may include nausea, headache, insomnia or drowsiness, and sexual dysfunction. Most side effects diminish within the first 2-4 weeks.

Buspirone: A Non-Addictive Alternative

Buspirone (BuSpar) is an anxiolytic medication that works through partial agonism of the serotonin 5-HT1A receptor. It is FDA-approved for GAD and has several advantages: it is non-addictive, does not cause sedation, does not impair cognition, and does not interact with alcohol. The main disadvantage is that it takes 2-4 weeks to work and must be taken consistently (not as-needed). It is less effective than SSRIs for panic disorder and social anxiety but works well for GAD, either alone or as an augmentation to an SSRI.

Benzodiazepines: Effective but Risky

Benzodiazepines -- including alprazolam (Xanax), lorazepam (Ativan), clonazepam (Klonopin), and diazepam (Valium) -- are the fastest-acting anti-anxiety medications available. They enhance GABA transmission and can relieve acute anxiety within 30-60 minutes.

The problem: Benzodiazepines carry significant risks that must be carefully weighed against their benefits.

• Physical dependence: Develops with regular use over weeks to months. Withdrawal can be medically dangerous (seizures, delirium) and must be managed with a gradual taper.
• Tolerance: The same dose becomes less effective over time, leading to dose escalation.
• Cognitive impairment: Memory impairment, slowed processing speed, reduced psychomotor performance. Particularly concerning in older adults (increased fall risk, accelerated cognitive decline).
• Interaction with substances: Combining benzodiazepines with alcohol or opioids can be fatal.
• Rebound anxiety: Anxiety often worsens when benzodiazepines are discontinued, creating a cycle of dependence.

I prescribe benzodiazepines judiciously in my practice. They have a role for short-term use during acute crises, for specific situational anxiety (such as flying phobia), and as a bridge while waiting for SSRIs to take effect. But they are not appropriate as first-line, long-term monotherapy for anxiety disorders. I have treated many patients who were placed on daily benzodiazepines by prior providers and now find themselves dependent, needing a carefully managed taper that can take months.

Other Medications

Hydroxyzine (Vistaril): An antihistamine with anxiolytic properties. Non-addictive, works within an hour, useful for as-needed anxiety without benzodiazepine risks. Main side effect is sedation.

Gabapentin and pregabalin: Sometimes used off-label for anxiety, particularly social anxiety and GAD. Pregabalin (Lyrica) is approved for GAD in Europe but not the United States. These carry their own dependence risks, though less than benzodiazepines.

Beta-blockers (propranolol): Do not treat the cognitive component of anxiety but can effectively block physical symptoms -- racing heart, trembling, sweating. Useful for performance anxiety (public speaking, auditions) when used 30-60 minutes before the event.

Psychotherapy for Anxiety

Cognitive Behavioral Therapy (CBT) is the most well-studied and effective psychotherapy for anxiety disorders. It works by identifying and challenging distorted thought patterns (cognitive restructuring) and gradually confronting feared situations (behavioral activation and exposure). Meta-analyses consistently show CBT produces large effect sizes across all anxiety disorders, and its effects are durable -- meaning improvement persists after treatment ends.

A typical course of CBT for anxiety involves 12-16 weekly sessions and includes psychoeducation about anxiety, cognitive restructuring (identifying and challenging catastrophic thoughts), relaxation training, and graded exposure to feared situations.

Exposure therapy is particularly effective for specific phobias, social anxiety, and panic disorder with agoraphobia. The principle is straightforward: gradual, repeated exposure to the feared stimulus in a safe, controlled environment leads to habituation (the anxiety response diminishes over time) and corrective learning (the person learns that the feared outcome does not occur).

Acceptance and Commitment Therapy (ACT) takes a different approach, focusing not on reducing anxiety but on changing one's relationship to it. Patients learn to observe anxious thoughts without fusing with them, accept uncomfortable feelings without avoidance, and commit to value-driven behavior regardless of anxiety. ACT has growing evidence for anxiety disorders and may be particularly useful for patients who have not responded to traditional CBT.

My Approach to Treating Anxiety at Integrative Psych

At my practice, Integrative Psych, located at 80 Eighth Avenue in Chelsea, Manhattan, I take a comprehensive approach to anxiety treatment that begins with thorough diagnostic assessment.

What a first visit looks like:

• Comprehensive psychiatric evaluation: 60-90 minute initial assessment covering current symptoms, symptom history, developmental history, family history, medical history, substance use, and previous treatments.
• Differential diagnosis: Determining whether symptoms are due to an anxiety disorder, ADHD, depression, bipolar disorder, thyroid dysfunction, substance use, or a combination. This distinction is critical because treatment differs.
• Severity assessment: Using validated rating scales (GAD-7, PHQ-9, social phobia inventory) to quantify symptom severity and track treatment response.
• Collaborative treatment planning: Discussing medication options, therapy referrals, and lifestyle modifications. I believe patients should understand their treatment and participate in decisions.

My particular strength as a clinician is managing complex presentations -- anxiety that co-occurs with ADHD, depression, substance use, or trauma. These comorbid cases require nuanced psychopharmacology and a provider who understands how different conditions interact. For example, treating anxiety in a patient with comorbid ADHD requires careful consideration of how stimulant medications affect anxiety, whether to treat the ADHD or anxiety first, and how to monitor for adverse effects. My research background at Columbia informs every clinical decision I make.

Comorbid Anxiety: When Anxiety Co-Occurs with Other Conditions

Anxiety and Depression

Anxiety and depression co-occur in approximately 60% of cases. This is so common that some researchers have proposed a "common factor" model suggesting both conditions share underlying vulnerability in emotion regulation circuitry. Fortunately, SSRIs and SNRIs treat both conditions simultaneously, and CBT techniques are effective for both. When anxiety and depression co-occur, treatment outcomes are generally slightly worse than for either condition alone, and treatment duration is typically longer.

Anxiety and ADHD

As discussed above, approximately 25-50% of adults with ADHD have a co-occurring anxiety disorder. Treatment requires careful sequencing and monitoring, which is one of my areas of clinical expertise. See ADHD vs. Anxiety for a comprehensive discussion.

Anxiety and Substance Use

Many patients with untreated anxiety self-medicate with alcohol, cannabis, or other substances. While these may provide temporary relief, they worsen anxiety in the long run through neuroadaptation, withdrawal effects, and disruption of sleep architecture. In my research on cannabis and anxiety, I have examined how cannabis use -- particularly high-THC products -- can exacerbate anxiety symptoms and even trigger panic attacks in vulnerable individuals. Effective treatment requires addressing both the anxiety disorder and the substance use simultaneously.

When to See a Psychiatrist vs. a Therapist for Anxiety

This is one of the most common questions I receive, and the answer depends on the severity and complexity of your symptoms.

See a psychiatrist if:

• Your anxiety is severe enough to significantly impair work, relationships, or daily functioning
• You want to explore medication options
• Therapy alone has been insufficient
• You have co-occurring conditions (ADHD, depression, bipolar disorder, substance use)
• You are experiencing panic attacks
• You have physical symptoms of anxiety that need medical evaluation
• You are currently on psychiatric medications that need management
• Previous treatment has been ineffective

A therapist may be sufficient if:

• Your anxiety is mild to moderate
• You are not interested in medication
• You have a specific, focused issue (such as a phobia or situational anxiety)
• You have no co-occurring psychiatric conditions

In practice, the most effective treatment for moderate to severe anxiety is the combination of medication and therapy. A psychiatrist can prescribe and manage medication while coordinating with a therapist for CBT or exposure therapy. At Integrative Psych, I work collaboratively with therapists to ensure comprehensive, coordinated care.

Lifestyle Modifications That Support Anxiety Treatment

While medication and therapy are the primary treatments, several lifestyle factors significantly influence anxiety severity.

Exercise: Robust evidence supports regular aerobic exercise as an anxiolytic. A 2019 meta-analysis in the British Journal of Sports Medicine found that exercise had a moderate-to-large effect on anxiety symptoms. The mechanism likely involves endorphin release, downregulation of the HPA axis, and increased brain-derived neurotrophic factor (BDNF). I recommend at least 150 minutes of moderate-intensity aerobic exercise per week.

Sleep: Sleep deprivation is one of the most potent anxiety triggers. The amygdala becomes up to 60% more reactive after sleep deprivation (Walker, 2009). Prioritizing 7-9 hours of quality sleep, maintaining consistent sleep-wake times, and addressing sleep disorders is critical.

Caffeine: Caffeine is an adenosine receptor antagonist that increases norepinephrine and cortisol levels. For many patients with anxiety disorders, caffeine significantly worsens symptoms. I often recommend reducing or eliminating caffeine as a first step -- particularly for patients with panic disorder, where caffeine can trigger panic attacks.

Alcohol: While alcohol initially reduces anxiety through GABA enhancement, it causes rebound anxiety as it is metabolized. Chronic alcohol use downregulates GABA receptors and upregulates glutamate receptors, leading to a state of neural hyperexcitability that worsens anxiety. I counsel patients to minimize alcohol consumption, particularly if they notice a pattern of increased anxiety the day after drinking.

Mindfulness and meditation: Growing evidence supports mindfulness-based stress reduction (MBSR) and mindfulness-based cognitive therapy (MBCT) for anxiety. These practices do not replace medication or therapy but can complement them by strengthening the prefrontal cortex's capacity to regulate amygdala reactivity.

What to Expect from Treatment: Realistic Timelines

Patients often ask me how quickly they will feel better. Here is an honest timeline based on evidence and my clinical experience:

• Week 1-2: If starting an SSRI/SNRI, anxiety may transiently worsen before improving. This is normal and expected. Therapy begins with psychoeducation and assessment.
• Week 2-4: First signs of medication response. Sleep and appetite often improve first. Worry may begin to decrease.
• Week 4-8: Full medication effect typically reached. CBT exposure work begins in earnest. Patients start noticing they can do things that previously felt impossible.
• Month 2-4: Significant improvement in most patients. Continued refinement of medication dose and therapy techniques.
• Month 6-12: Consolidation of gains. Therapy frequency may decrease. Discussion about long-term medication strategy.

Most guidelines recommend continuing medication for at least 12 months after remission to reduce relapse risk. For patients with chronic, recurrent anxiety, longer-term or indefinite medication may be appropriate. Therapy skills, once learned, provide lasting benefits even after formal therapy ends.

Why Choose a Psychiatrist at Columbia University for Anxiety Treatment

Not all anxiety treatment is equal. As a faculty member at Columbia University Irving Medical Center and a researcher funded by the National Institute on Drug Abuse (NIDA), I bring a depth of knowledge that goes beyond clinical training alone. My published research -- including a study cited over 411 times in JAMA Internal Medicine -- informs my understanding of prescribing patterns, medication safety, and the latest evidence base.

I am board-certified in both adult psychiatry and child and adolescent psychiatry, which means I can treat anxiety across the lifespan and recognize how it manifests differently at different developmental stages. Whether you are a college student experiencing your first panic attack, a working professional struggling with social anxiety, or a parent worried about your child's anxiety, I have the training and experience to help.

Further Reading

• ADHD vs. Anxiety: How to Tell the Difference
• Depression Treatment with Dr. Sultan
• Cannabis and Anxiety: What the Research Shows
• Complete ADHD Guide
• OCD Treatment NYC